Oncolytic Viruses and Immune Checkpoint Inhibition: The Best of Both Worlds
Oncolytic Viruses and Immune Checkpoint Inhibition: The Best of Both Worlds
About this item
Full title
Author / Creator
Publisher
United States: Elsevier Inc
Journal title
Language
English
Formats
Publication information
Publisher
United States: Elsevier Inc
Subjects
More information
Scope and Contents
Contents
Cancer immunotherapy and the emergence of immune checkpoint inhibitors have markedly changed the treatment paradigm for many cancers. They function to disrupt cancer cell evasion of the immune response and activate sustained anti-tumor immunity. Oncolytic viruses have also emerged as an additional therapeutic agent for cancer treatment. These virus...
Alternative Titles
Full title
Oncolytic Viruses and Immune Checkpoint Inhibition: The Best of Both Worlds
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_d33d49ee949345dca50945b79a95b869
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d33d49ee949345dca50945b79a95b869
Other Identifiers
ISSN
2372-7705
E-ISSN
2372-7705
DOI
10.1016/j.omto.2019.04.003
